Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Torres

Showing results (1-10 of 356) with videos related to

Pageof 36
Sort By:
Revista Medica De Chile|January 21, 2015
[Specifying the "environmental effect on the incidence of Hantavirus cardiopulmonary syndrome in Chile"]Fernando Torres-Pérez
Expert Review of Cardiovascular Therapy|December 25, 2012
Treprostinil for the treatment of pulmonary arterial hypertensionFernando Torres, Lewis J Rubin
Heart Failure Reviews|May 16, 2016
Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantationSonja Darrell Bartolome, Fernando Torres
Clinics in Laboratory Medicine|August 25, 2004
Emerging infections in animals--potential new zoonoses?Fernando Torres-Vélez, Corrie Brown
Accounts of Chemical Research|June 23, 2012
Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterialsFernando Torres Andón, Bengt Fadeel
Sensors (Basel, Switzerland)|May 13, 2023
Assistance Robotics and SensorsSantiago T Puente, Fernando Torres
Nanomaterials (Basel, Switzerland)|November 27, 2021
Recent Discoveries in Nanoparticle-Macrophage Interactions: In Vitro Models for Nanosafety Testing and Novel Nanomedical Approaches for ImmunotherapyFernando Torres Andón, Olesja Bondarenko
Viruses|October 14, 2011
Hantaviruses in the americas and their role as emerging pathogensBrian Hjelle, Fernando Torres-Pérez
Journal of Drug Targeting|October 11, 2015
Nanomedicine and cancer immunotherapy - targeting immunosuppressive cellsFernando Torres Andón, María José Alonso
Molecular Carcinogenesis|January 14, 2011
5,7,3'-Trihydroxy-3,4'-dimethoxyflavone inhibits the tubulin polymerization and activates the sphingomyelin pathwayFernando Torres, José Quintana, Francisco Estévez
Pageof 36

Showing results (1-10 of 356) with videos related to

Sort By:
Pageof 36
Revista Medica De Chile|January 21, 2015
[Specifying the "environmental effect on the incidence of Hantavirus cardiopulmonary syndrome in Chile"]Fernando Torres-Pérez
Expert Review of Cardiovascular Therapy|December 25, 2012
Treprostinil for the treatment of pulmonary arterial hypertensionFernando Torres, Lewis J Rubin
Heart Failure Reviews|May 16, 2016
Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantationSonja Darrell Bartolome, Fernando Torres
Clinics in Laboratory Medicine|August 25, 2004
Emerging infections in animals--potential new zoonoses?Fernando Torres-Vélez, Corrie Brown
Accounts of Chemical Research|June 23, 2012
Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterialsFernando Torres Andón, Bengt Fadeel
Sensors (Basel, Switzerland)|May 13, 2023
Assistance Robotics and SensorsSantiago T Puente, Fernando Torres
Nanomaterials (Basel, Switzerland)|November 27, 2021
Recent Discoveries in Nanoparticle-Macrophage Interactions: In Vitro Models for Nanosafety Testing and Novel Nanomedical Approaches for ImmunotherapyFernando Torres Andón, Olesja Bondarenko
Viruses|October 14, 2011
Hantaviruses in the americas and their role as emerging pathogensBrian Hjelle, Fernando Torres-Pérez
Journal of Drug Targeting|October 11, 2015
Nanomedicine and cancer immunotherapy - targeting immunosuppressive cellsFernando Torres Andón, María José Alonso
Molecular Carcinogenesis|January 14, 2011
5,7,3'-Trihydroxy-3,4'-dimethoxyflavone inhibits the tubulin polymerization and activates the sphingomyelin pathwayFernando Torres, José Quintana, Francisco Estévez
Pageof 36